Literature DB >> 18162340

Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture.

Adchara Pongpeerapat1, Chalermphon Wanawongthai, Yuichi Tozuka, Kunikazu Moribe, Keiji Yamamoto.   

Abstract

The purpose of this study was to investigate the formation mechanism of colloidal nanoparticles after dispersion of probucol/polyvinylpyrrolidone (PVP)/sodium dodecyl sulphate (SDS) ternary ground mixture (GM) into water. Probucol, PVP and SDS were mixed at a weight ratio of 1:3:1 and ground for 30 min with a vibrational rod mill. The morphology and physicochemical properties were investigated through high resolution scanning electron microscopy (SEM), environmental SEM, dynamic light scattering, (13)C NMR and zeta potential measurements. SEM images confirmed the presence of 20 nm size primary particles in the GM powder of probucol/PVP K17/SDS. Spherical nanoparticles with a size of around 100 nm, formed after dispersion of the GM into water, suggested an agglomeration of the primary particles. A further agglomeration of around 160 nm was observed with the stability experiment. Zeta potential and particle size measurements using latex beads revealed that PVPK 17/SDS complex was adsorbed on the probucol particle surface forming a layered structure. A similar agglomeration behavior was observed using the GM of probucol/PVP K12/SDS, though the molecular state of the PVPK 12/SDS complex at the particle surface was different from that of the PVPK 17/SDS complex. (13)C NMR results suggested that intermolecular interactions between PVP K12 and SDS did not reach the same level as the interactions between PVP K17 and SDS. This study proposed a formation mechanism of colloidal nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162340     DOI: 10.1016/j.ijpharm.2007.10.052

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug.

Authors:  Deng-Guang Yu; Li-Dong Gao; Kenneth White; Christopher Branford-White; Wei-Yue Lu; Li-Min Zhu
Journal:  Pharm Res       Date:  2010-08-19       Impact factor: 4.200

2.  Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs.

Authors:  Toshiyuki Niwa; Satoru Miura; Kazumi Danjo
Journal:  Pharm Res       Date:  2011-05-28       Impact factor: 4.200

3.  Homogeneous nanoparticles to enhance the efficiency of a hydrophobic drug, antihyperlipidemic probucol, characterized by solid-state NMR.

Authors:  Takeshi Io; Toshiro Fukami; Kazutoshi Yamamoto; Toyofumi Suzuki; Jiadi Xu; Kazuo Tomono; Ayyalusamy Ramamoorthy
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

4.  Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation.

Authors:  Zhiwen Zhang; Shijun Jiang; Zeying Liu; Baohua Niu; Wangwen Gu; Yaping Li; Jingbin Cui
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

5.  Evaluation of nanodispersion of iron oxides using various polymers.

Authors:  Y Tanaka; H Ueyama; M Ogata; T Daikoku; M Morimoto; A Kitagawa; Y Imajo; T Tahara; M Inkyo; N Yamaguchi; S Nagata
Journal:  Indian J Pharm Sci       Date:  2014-01       Impact factor: 0.975

6.  Continuous production of lignin nanoparticles using a microchannel reactor and its application in UV-shielding films.

Authors:  Ting Ju; Zhiliang Zhang; Yang Li; Xinfeng Miao; Jianbing Ji
Journal:  RSC Adv       Date:  2019-08-12       Impact factor: 3.361

7.  Self-assembled organic-inorganic magnetic hybrid adsorbent ferrite based on cyclodextrin nanoparticles.

Authors:  Angelo M L Denadai; Frederico B De Sousa; Joel J Passos; Fernando C Guatimosim; Kirla D Barbosa; Ana E Burgos; Fernando Castro de Oliveira; Jeann C da Silva; Bernardo R A Neves; Nelcy D S Mohallem; Rubén D Sinisterra
Journal:  Beilstein J Org Chem       Date:  2012-11-01       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.